Call Now
800-993-0005
      Home           About Us         Subscribe     Product Info        Media              Events       Conference Calls  
(^DJI) 0 0S&P 500 (^GSPC) 1295.22 -9.64NASDAQ Composite (^IXIC) 2778.79 -34.9Russell 2000 (^RUT) 747.21 0


iDayo™ Stock Selector: BMRN - Biomarin Pharmaceutical


iDayo™ 07/24/06: Biomarin Pharmaceutical (BMRN) - 07/24/06


For the 16 week investment period starting 07/24/06 , the iDayo™ Stock Selector rated Biomarin Pharmaceutical (BMRN) as "Heavy Accumulation" and selected BMRN as a buy for the investment period, identified as iDayo™ 07/24/06.

Company Profile for "Biomarin Pharmaceutical (BMRN)": BioMarin Pharmaceutical, Inc. engages in the development and commercialization of biopharmaceuticals for serious diseases and medical conditions.

Google Finance History for BMRN

iDayo™ 12/09/02: Biomarin Pharmaceutical (BMRN) - 12/09/02


For the 16 week investment period starting 12/09/02 , the iDayo™ Stock Selector rated Biomarin Pharmaceutical (BMRN) as "Heavy Accumulation" and selected BMRN as a buy for the investment period, identified as iDayo™ 12/09/02.

Company Profile for "Biomarin Pharmaceutical (BMRN)": BioMarin Pharmaceutical Inc. develops enzyme therapies to treat debilitating, life-threatening genetic diseases and other indications.

Google Finance History for BMRN